Penumbra PE Ratio 2014-2025 | PEN
Current and historical p/e ratio for Penumbra (PEN) from 2014 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Penumbra PE ratio as of July 04, 2025 is 76.31.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Penumbra PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-03 | 251.06 | 236.85 | |
| 2025-03-31 | 267.41 | $1.06 | 252.27 |
| 2024-12-31 | 237.48 | $0.34 | 698.47 |
| 2024-09-30 | 194.31 | $0.86 | 225.94 |
| 2024-06-30 | 179.97 | $0.34 | 529.32 |
| 2024-03-31 | 223.18 | $2.37 | 94.17 |
| 2023-12-31 | 251.54 | $2.31 | 108.89 |
| 2023-09-30 | 241.91 | $1.03 | 234.86 |
| 2023-06-30 | 344.06 | $0.74 | 464.95 |
| 2023-03-31 | 278.69 | $0.16 | 1741.81 |
| 2022-12-31 | 222.46 | $-0.06 | 0.00 |
| 2022-09-30 | 189.60 | $-0.82 | 0.00 |
| 2022-06-30 | 124.52 | $-0.52 | 0.00 |
| 2022-03-31 | 222.13 | $-0.17 | 0.00 |
| 2021-12-31 | 287.32 | $0.15 | 1915.47 |
| 2021-09-30 | 266.50 | $0.91 | 292.86 |
| 2021-06-30 | 274.06 | $0.43 | 637.35 |
| 2021-03-31 | 270.58 | $-0.16 | 0.00 |
| 2020-12-31 | 175.00 | $-0.44 | 0.00 |
| 2020-09-30 | 194.38 | $-0.27 | 0.00 |
| 2020-06-30 | 178.82 | $0.29 | 616.62 |
| 2020-03-31 | 161.33 | $1.09 | 148.01 |
| 2019-12-31 | 164.27 | $1.35 | 121.68 |
| 2019-09-30 | 134.49 | $1.26 | 106.74 |
| 2019-06-30 | 160.00 | $0.39 | 410.26 |
| 2019-03-31 | 147.01 | $0.30 | 490.03 |
| 2018-12-31 | 122.20 | $0.15 | 814.67 |
| 2018-09-30 | 149.70 | $0.22 | 680.45 |
| 2018-06-30 | 138.15 | $0.78 | 177.12 |
| 2018-03-31 | 115.65 | $0.36 | 321.25 |
| 2017-12-31 | 94.10 | $0.11 | 855.45 |
| 2017-09-30 | 90.30 | $-0.22 | 0.00 |
| 2017-06-30 | 87.75 | $-0.27 | 0.00 |
| 2017-03-31 | 83.45 | $-0.21 | 0.00 |
| 2016-12-31 | 63.80 | $-0.09 | 0.00 |
| 2016-09-30 | 75.99 | $0.04 | 1899.75 |
| 2016-06-30 | 59.50 | $0.11 | 540.91 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.723B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $195.148B | 85.47 |
| Thermo Fisher Scientific (TMO) | United States | $162.069B | 19.60 |
| Edwards Lifesciences (EW) | United States | $45.045B | 29.53 |
| IDEXX Laboratories (IDXX) | United States | $43.992B | 50.56 |
| Alcon (ALC) | Switzerland | $43.297B | 29.26 |
| DexCom (DXCM) | United States | $32.517B | 50.26 |
| IQVIA Holdings (IQV) | United States | $28.414B | 15.91 |
| Mettler-Toledo (MTD) | United States | $25.128B | 29.88 |
| STERIS (STE) | Ireland | $23.368B | 25.74 |
| Waters (WAT) | United States | $20.841B | 29.41 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.678B | 0.00 |
| Hologic (HOLX) | United States | $14.436B | 15.69 |
| Sysmex ADR (SSMXY) | Japan | $10.859B | 30.80 |
| Masimo (MASI) | United States | $9.085B | 33.51 |
| Globus Medical (GMED) | United States | $8.010B | 19.09 |
| Glaukos (GKOS) | United States | $5.914B | 0.00 |
| Teleflex (TFX) | United States | $5.298B | 8.75 |
| TransMedics (TMDX) | United States | $4.370B | 94.99 |
| Integer Holdings (ITGR) | United States | $4.222B | 22.12 |
| PROCEPT BioRobotics (PRCT) | United States | $3.205B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.515B | 14.98 |
| Nihon Kohden (NHNKY) | Japan | $2.346B | 26.90 |
| Veracyte (VCYT) | United States | $2.154B | 30.23 |
| Elekta AB (EKTAY) | Sweden | $1.991B | 17.90 |
| Alphatec Holdings (ATEC) | United States | $1.606B | 0.00 |
| Artivion (AORT) | United States | $1.312B | 122.88 |
| Tandem Diabetes Care (TNDM) | United States | $1.118B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.048B | 5.57 |
| Pulse Biosciences (PLSE) | United States | $1.029B | 0.00 |
| SiBone (SIBN) | United States | $0.787B | 0.00 |
| IRadimed (IRMD) | United States | $0.786B | 39.87 |
| Beta Bionics (BBNX) | United States | $0.586B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.571B | 8.88 |
| Mesa Laboratories (MLAB) | United States | $0.564B | 13.22 |
| OrthoPediatrics (KIDS) | United States | $0.546B | 0.00 |
| RxSight (RXST) | United States | $0.530B | 0.00 |
| AxoGen (AXGN) | United States | $0.498B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.480B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.451B | 12.00 |
| Delcath Systems (DCTH) | United States | $0.442B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.436B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.389B | 0.00 |
| NeuroPace (NPCE) | United States | $0.341B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.327B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.284B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.269B | 0.00 |
| 908 Devices (MASS) | United States | $0.238B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.27 |
| Neuronetics (STIM) | United States | $0.224B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.218B | 0.00 |
| Inogen (INGN) | United States | $0.201B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.159B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Accuray (ARAY) | United States | $0.146B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.111B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 46.60 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.11 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.026B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.07 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |